Laboratory markers in patients with COVID-19

Authors

DOI:

https://doi.org/10.33448/rsd-v9i12.11115

Keywords:

COVID-19; Biochemical markers; Blood tests.

Abstract

The new coronavirus causes the coronavirus disease 19 (COVID-19) and was first recognized in Wuhan, China, in December 2019. On March 11, 2020, the World Health Organization declared it a pandemic. The clinical course of COVID-19 can be classified into three stages, "early infection", "pulmonary phase" and "hyperinflammation phase", each one characterized by specific biochemical changes. The aim of this work is to describe the differences and the potential prognosis of routine blood tests in patients hospitalized in an infirmary and intensive care unit (ICU) diagnosed with COVID-19. It is a longitudinal and retrospective study in which data collection was performed through information contained in medical records. During the study period, 62 patients with confirmed SARS-CoV-2 infection were included. Of these, 32.2% required admission to the ICU and 67.8% were treated in infirmary. Among patients treated in the ICU, age, leukocytes, banded neutrophils, neutrophils, urea, creatinine, total bilirubin, LDH and D-dimer were higher compared to those who remained in the infirmary. On the other hand, hemoglobin and hematocrit in ICU patients were lower. We believe that leukocyte levels at the admission of the patient can indicate the severity of the disease and that monitoring the levels of hemoglobin, LDH and D-dimer during the hospitalization is important to assess the progression of the disease.

References

Bikdeli, B., Madhavan, M. V., Jimenez, D., Chuich, T., Dreyfus, I., Driggin, E., … Lip, G. Y. H. (2020). COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up. Journal of the American College of Cardiology, 75(23), 2950–2973. https://doi.org/10.1016/j.jacc.2020.04.031

CDC - Centers for Disease Control and Prevention. (2020). Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020. Morbidity and Mortality Weekly Report, 69(12), 343–346. https://doi.org/10.15585/mmwr.mm6912e2

Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., … Xu, G. (2020). Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney International, 97(5), 829–838. https://doi.org/10.1016/j.kint.2020.03.005

Ciaccio, M., & Agnello, L. (2020). Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19). Diagnosis, 7(4), 365-72. https://doi.org/10.1515/dx-2020-0057

Ferdian, F. (2020). Effect of increased BMI and obesity on the outcome of COVID-19 adult patients: A systematic review and meta-analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(6), 1897–1904. https://doi.org/10.1016/j.dsx.2020.09.029

Guan, W., Ni, Z., Hu, Y., Liang, W., Ou, C., He, J., … Zhong, N. (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine, 382(18), 1708–1720. https://doi.org/10.1056/nejmoa2002032.

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., … Cao, B. (2020a). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England), 395(10223), 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5.

Huang, J., Cheng, A., Lin, S., Zhu, Y., & Chen, G. (2020b). Individualized prediction nomograms for disease progression in mild COVID‐19. Journal of Medical Virology, 92(10), 2074–2080. https://doi.org/10.1002/jmv.25969

IBGE – Instituto Brasileiro de Geografia e Estatística (2018). Estimativa da população residente para os municípios e para as unidades da federação com data de referência em 10 de julho de 2018. Brasília: IBGE. Recuperado de https://www.ibge.gov.br/estatisticasnovoportaL/sociais/populacao/9103.

Joannidis, M., Forni, L. G., Klein, S. J., Honore, P. M., Kashani, K., Ostermann, M., … Kellum, J. A. (2020). Lung–kidney interactions in critically ill patients: Consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup. Intensive Care Medicine, 46(4), 654–672. https://doi.org/10.1007/s00134-019-05869-7

Kazancioglu, S., Bastug, A., Ozbay, B. O., Kemirtlek, N., & Bodur, H. (2020). The Role of Hematological Parameters in Patients with Coronavirus Disease 2019 and Influenza Virus Infection. Epidemiology and Infection, 1–16. https://doi.org/10.1017/S095026882000271X

Lana, R. M., Coelho, F. C., Gomes, M. F. da C., Cruz, O. G., Bastos, L. S., Villela, D. A. M., & Codeço, C. T. (2020). Emergência do novo coronavírus (SARS-CoV-2) e o papel de uma vigilância nacional em saúde oportuna e efetiva. Cadernos de Saúde Pública, 36(3), e00019620. https://doi.org/10.1590/0102-311x00019620

Lippi, G., & Plebani, M. (2020). Laboratory abnormalities in patients with COVID-2019 infection. Clinical Chemistry and Laboratory Medicine (CCLM), 58(7), 1131–1134. https://doi.org/10.1515/cclm-2020-0198

Liu, Y., Yang, Y., Zhang, C., Huang, F., Wang, F., Yuan, J., … Liu, L. (2020a). Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Science China. Life Sciences, 63(3), 364–374. https://doi.org/10.1007/s11427-020-1643-8.

Liu, Y., Du, X., Chen, J., Jin, Y., Peng, L., Wang, H., Luo, M., Chen, L., & Zhao, Y. (2020b). Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. The Journal of Infection, 81(1), e6–e12. https://doi.org/10.1016/j.jinf.2020.04.002.

Paliogiannis, P., & Zinellu, A. (2020). Bilirubin levels in patients with mild and severe Covid‐19: A pooled analysis. Liver International, 40(7), 1787–1788. https://doi.org/10.1111/liv.14477

Paliogiannis, P., Zinellu, A., Scano, V., Mulas, G., De Riu, G., ... Fois, A. G. (2020a). Laboratory test alterations in patients with COVID-19 and non COVID-19 interstitial pneumonia: a preliminary report. Journal of Infection in Developing Countries, 14(7), 685–690. https://doi.org/10.3855/jidc.12879.

Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., … Zanos, T. P. (2020). Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA, 323(20), 2052. https://doi.org/10.1001/jama.2020.6775

Soeroto, A. Y., Soetedjo, N. N., Purwiga, A., Santoso, P., Kulsum, I. D., Suryadinata, H., & Ferdian, F. (2020). Effect of increased BMI and obesity on the outcome of COVID-19 adult patients: A systematic review and meta-analysis. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14(6), 1897–1904. https://doi.org/10.1016/j.dsx.2020.09.029.

Vekaria, B., Overton, C., Wisniowski, A., Ahmad, S., Aparicio-Castro, A., Curran-Sebastian, J., … Elliot, M. (2020). Hospital Length of Stay For COVID-19 Patients: Data-Driven Methods for Forward Planning [Preprint]. In Review. https://doi.org/10.21203/rs.3.rs-56855/v1

Violetis, O. A., Chasouraki, A. M., Giannou, A. M., & Baraboutis, I. G. (2020). COVID-19 Infection and Haematological Involvement: A Review of Epidemiology, Pathophysiology and Prognosis of Full Blood Count Findings. SN Comprehensive Clinical Medicine, 2(8), 1089–1093. https://doi.org/10.1007/s42399-020-00380-3

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., ... Peng, Z. (2020). Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China. JAMA, 323(11), 1061–1069. https://doi.org/10.1001/jama.2020.1585.

Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., … Wang, F.-S. (2020). Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory Medicine, 8(4), 420–422. https://doi.org/10.1016/S2213-2600(20)30076-X

Yang, W., Cao, Q., Qin, L., Wang, X., Cheng, Z., Pan, A., … Yan, F. (2020). Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China. Journal of Infection, 80(4), 388–393. https://doi.org/10.1016/j.jinf.2020.02.016

Ye, Q., Wang, B., & Mao, J. (2020). The pathogenesis and treatment of the `Cytokine Storm’ in COVID-19. Journal of Infection, 80(6), 607–613. https://doi.org/10.1016/j.jinf.2020.03.037

Yi, Y., Lagniton, P. N. P., Ye, S., Li, E., & Xu, R.-H. (2020). COVID-19: What has been learned and to be learned about the novel coronavirus disease. International Journal of Biological Sciences, 16(10), 1753–1766. https://doi.org/10.7150/ijbs.45134

Zhang, G., Zhang, J., Wang, B., Zhu, X., Wang, Q., & Qiu, S. (2020). Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A retrospective analysis. Respiratory Research, 21(1), 74. https://doi.org/10.1186/s12931-020-01338-8

Published

25/12/2020

How to Cite

CARELLI, G. Z. .; CARVALHO, B. R. de B. .; MOLIN, B. D. .; DUARTE, C. R.; MARTINS, G. K. F. .; WENDT, G. W. .; SILVA, M. C. B. .; GUEDES, S. J. K. O. .; FERRETO, L. E. D. . Laboratory markers in patients with COVID-19. Research, Society and Development, [S. l.], v. 9, n. 12, p. e30191211115, 2020. DOI: 10.33448/rsd-v9i12.11115. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/11115. Acesso em: 12 nov. 2024.

Issue

Section

Health Sciences